LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the third quarter ended September 30, 2011.
“Our outstanding financial performance in Q3 is another important milestone in the transformational year we are having at Cubist” Third Quarter 2011 Highlights:
•Net U.S. Product Revenues of $186.4 million up 21% over the third quarter of 2010 •GAAP Basic and Diluted Net Income of $0.40 and $0.33 per share, respectively •Non-GAAP Basic and Diluted Net Income of $1.11 and $0.85 per share, respectively •Raising net U.S. product revenue guidance to a range of between $695 and $700 Million •Raising total net revenue guidance to a range of between $740 and $745 Million •Earnings’ conference call & webcast today (with slides) at 5:00 p.m. ET